Showing all 6 results
Levamisole Tablets
FreeProduct Composition & Available Strengths
We supply Levamisole Hydrochloride across the two primary compendial configurations required to execute precise pediatric deworming courses or adult high-mass therapeutic maintenance.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levamisole Hydrochloride USP / BP / IP 50 mg Oral Solid Uncoated / Chewable Tablet Pediatric Deworming & Titration: Low-dose format calibrated for exact mass titration in pediatric ascariasis or low-dose immunomodulatory courses. Levamisole Hydrochloride USP / BP / IP 150 mg Oral Solid Compressed Tablet The Core Commercial Volume: High-potency, single-dose adult baseline format optimized for rapid mass community deworming campaigns. Loperamide Tablet
FreeProduct Composition & Configuration
We supply Loperamide Hydrochloride in the internationally standardized 2 mg therapeutic dosage configuration, engineered for rapid disintegration and fast symptomatic relief.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Loperamide Hydrochloride USP / BP / IP 2 mg Oral Solid Immediate-Release Uncoated Tablet Fast-Acting Anti-Diarrheal: Non-specific acute diarrhea management, chronic diarrheal stabilization, and ileostomy output reduction. Excipients Pharma Grade Lactose Monohydrate, Microcrystalline Cellulose, Corn Starch, Magnesium Stearate The Disintegration Scaffold: Optimized matrix for high mechanical stability and rapid water wicking. Methyl Ergonovine Maleate Tablet
FreeProduct Composition & Calibration Strength
We manufacture this critical emergency therapeutic in the globally accepted standard micro-dose strength optimized for postpartum routine oral management.
Active Ingredient Common Name Compendial Monograph Standard Strength Primary Clinical Target Methyl Ergonovine Maleate (Methylergometrine Maleate) USP / BP / IP 0.2 mg (200 mcg) The Uterotoner Matrix: Administered orally following initial IV/IM stabilization to maintain uterine tone and prevent bleeding recurrence. Excipients Pharma Grade Lactose, Starch, Povidone binders The Delivery Scaffold: Engineered for rapid physical disintegration and quick mucosal absorption. Methyldopa Tablet
FreeProduct Composition & Available Strengths
We supply Methyldopa in standard, exact strengths designed to facilitate the careful, progressive dose titration required in gestational healthcare.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Methyldopa Anhydrous IP / BP / USP 250 mg Oral Solid Film-Coated Tablet (Scored for micro-titration) Initial Titration / Baseline Care: For early-stage gestational hypertension and lower-dose fine-tuning. Methyldopa Anhydrous IP / BP / USP 500 mg Oral Solid Film-Coated Tablet (Engineered for uniform mass release) High-Potency Maintenance: For advanced chronic hypertension during pregnancy and severe pre-eclamptic stabilization. Norfloxacin Tablet
FreeProduct Composition & Strength
We supply Norfloxacin in the globally standardized therapeutic strength optimized for adult twice-daily dosage regimens.
Active Ingredient Strength (per Tablet) Primary Microbiological Function Norfloxacin USP / BP / IP 400 mg The DNA Gyrase Blocker: Eradicates susceptible urinary and gastrointestinal pathogens. Excipients Pharma Grade The Core Matrix: High-performance binders optimized for rapid tablet dissolution. Sulphadiazine Tablets
FreeSulphadiazine Tablets IP
Each Uncoated Tablets Contains:
Sulphadiazine IP 500 mgUsage: – urinary tract infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
